Tilo Freiwald

@tilofrei.bsky.social

Complementologist | BMBF iSTAR Advanced Clinician Scientist at UKE | formerly NIH Afzali Lab and Kemper Lab | co-founder Amboss | http://freiwaldlab.com

Hamburg News: ⁦@PuellesVictor⁩ and collaborators push tissue analytics to the next frontier. This also marks a remarkable academic path: from postdoc to junior professor in our group to full professor at ⁦@UKEHamburg⁩ & ⁦@AarhusUni⁩ ⁦‪@Nature‬⁩ www.nature.com/articles/s41...

Pathology-oriented multiplexing enables integrative disease mapping - Nature

Pathology-oriented multiplexing (PathoPlex) represents a framework for widespread access to multiplexed imaging and computational image analysis of clinical specimens at a relatively high through...

nature.com

@ambossmed closes €240M financing round to expand its position as the leading co-pilot for physicians worldwide 🚀The round saw participation from new long-term investors KIRKBI, M&G Investments & Lightrock alongside existing shareholders, including us. 1/6

Bild